Seventure Partners

Founded 1997

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 186
Average round size
info
The average size of a deal this fund participated in
$10M
Portfolio companies 156
Rounds per year 7.75
Lead investments 60
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.26
Exits 50
Key employees 9
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity

Areas of investment

  • Biotechnology
  • Health Care
  • Software
  • Therapeutics
  • Medical Device
Summary

Seventure Partners appeared to be the VC, which was created in 1997. The company was established in Europe in France. The main office of represented VC is situated in the Paris.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Seventure Partners, startups are often financed by Sofinnova Partners, Societe Generale Asset Management, Alven Capital. The meaningful sponsors for the fund in investment in the same round are XAnge, Sofinnova Partners, Omnes Capital. In the next rounds fund is usually obtained by Bpifrance, EASME - EU Executive Agency for SMEs, Auriga Partners.

For fund there is a match between the location of its establishment and the land of its numerous investments - France. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has no exact preference in some founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Among the most popular fund investment industries, there are Health Care, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight DayTwo, Launchmetrics, BIOMx.

The fund is generally included in 7-12 deals every year. The increased amount of exits for fund were in 2016. The average startup value when the investment from Seventure Partners is 10-50 millions dollars. The important activity for fund was in 2017. Despite it in 2019 the fund had an activity. Deals in the range of 5 - 10 millions dollars are the general things for fund. Speaking about the real fund results, this VC is 16 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this Seventure Partners performs on 2 percentage points less the average number of lead investments.

We also calculated 12 valuable employees in our database.

Read more

Notable deals

CompanyIndustryRoundRound SizeDateInvestorsLocation

Proteon Pharmaceuticals

Biotechnology
n/a
$24M10 Aug 2021 Poland, Łódź

Otoqi

Automotive
Delivery
Industrial
1
$7M15 Jul 2021 France, Paris

Dopavision

Biotechnology
Health Care
Medical Device
Therapeutics
1
$14M14 Jul 2021 Germany, Berlin

SportEasy

Identity Management
Sports
1
$5M21 Jun 2021 France, Paris

Biotechnology
Life Science
1
$45M04 May 2021 Denmark, " Denmark"}

Expensya

Accounting
FinTech
Mobile Apps
SaaS
Software
1
$20M30 Apr 2021 France, Paris

PEP-Therapy

Biotechnology
Medical
Therapeutics
1
$3M22 Apr 2021 France, Évry-Courcouronnes

Hepster

Financial Services
Insurance
InsurTech
1
$10M05 Mar 2021 Germany, Rostock

Ervaccine Technologies

Biotechnology
Pharmaceutical
1
$2M10 Feb 2021 France, Lyon
News
Dopavision Raises €12M in Series A Funding

– Dopavision, a Berlin, Germany-based company focused on development of digital therapeutics, raised €12M in Series A funding.
– The round was led by Seventure Partners with participation from Novartis Pharmaceuticals, Boehringer Ingelheim Venture Fund and Ababax Health.
– The new investment will be used for the clinical development of MyopiaX, its lead product in childhood myopia, activities to provide innovative digital treatments for children leveraging games, educational or cognitive training applications, and potentially broaden its pipeline to new indications.

Foodsmart Scores Over $25M

– Foodsmart, the personalized telenutrition and foodcare leader, has announced a Series C funding of more than $25m.
– The round was led by Advocate Aurora Enterprises, a newly launched subsidiary of Advocate Aurora Health, one of the largest health systems in the United States.
– Foodsmart’s Series C round also included participation from Mayfield Fund, Seventure Partners (Health for Life Capital), New Ground Ventures, Benefitfocus Founder Shawn Jenkins, Classpass CEO Fritz Lanman and former Darden Restaurants CEO Clarence Otis.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Seventure Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: